Cardiovascular effects of short-term growth hormone hypersecretion

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 179-182

  Fazio, Serafino ^a,b   Cittadini, Antonio ^a   Biondi, Bernadette ^a   Palmieri, Emiliano Antonio ^a   Riccio, Giuseppe ^a   Bonè, Filomena ^a   Oliviero, Ugo ^a   Saccà, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Vico Equense/Sorrento   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ACROMEGALY; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; HORMONE ACTION; HORMONE RELEASE; HUMAN; MALE; PRIORITY JOURNAL; VASCULAR RESISTANCE;

EID: 0034455408     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.1.6313     Document Type: Article

References (29)

1. Heart muscle disease in acromegaly
2. Cardiac size and function in acromegaly
3. Heart size and function in acromegaly
4. Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study
5. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly
6. Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics
7. Effects of excessive secretion of growth hormone on tissue of the rat, with particular reference to the heart and skeletal muscle
8. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosine adenosine triphosphatase activity of rat left ventricle
9. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion
10. Differential cardiac effects of growth hormone and IGF-I in the rat: A combined in vivo and in vitro evaluation
11. Exogenously administered growth hormone and IGF-I alter intracellular calcium handling and enhance cardiac performance: In vitro evaluation in the isolated isovolumic buffer perfused rat heart
12. Increased myocardial contractility following growth hormone administration in normal men
13. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiography measurements
14. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods
15. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography: A comparison of cineangiographic and radionuclide techniques
16. Cardiac catheterization
17. Growth hormone and the heart
18. Cardiac function in acromegaly
19. A hyperkinetic heart in uncomplicated active acromegaly: Explanation of hypertension in acromegalic patients?
20. Water and sodium in patients with acromegaly
21. Characteristics of the antinatriuretic action of growth hormone
22. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man
23. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
24. Growth hormone, cardiomyocyte contractile reserve, and heart failure
25. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy. Effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity
26. Growth hormone attenuate early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction
27. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction
28. Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with ocreotide
29. Haemodynamic effects of intravenous growth hormone in congestive heart failure